CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice

International Immunopharmacology

Volumn 19, Issue 1, 2014, Pages 74-80

  Ma, Jinzhu ^a,b,c   Wang, Hualei ^b   Zheng, Xuexing ^b   Xue, Xianghong ^b   Wang, Beiyan ^c   Wu, Hongxia ^b   Zhang, Kun ^b   Fan, Shengtao ^b   Wang, Tiecheng ^b   Li, Nan ^b   Zhao, Yongkun ^b   Gao, Yuwei ^b   Yang, Songtao ^b   Xia, Xianzhu ^a,b  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adjuvant; DNA vaccine; Eastern equine encephalitis virus; Immunogenicity; Pseudoviruses; Recombinant plasmid

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID;

ADJUVANT; DNA VACCINE; EASTERN EQUINE ENCEPHALITIS VIRUS; IMMUNOGENICITY; PSEUDOVIRUSES; RECOMBINANT PLASMID;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CPG ISLANDS; CYTOKINES; ENCEPHALITIS VIRUS, EASTERN EQUINE; FEMALE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; POLY I-C; T-LYMPHOCYTES; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84893321248     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.01.002     Document Type: Article

References (37)

1. P. Vogel, W.M. Kell, D.L. Fritz, M.D. Parker, and R.J. Schoepp Early events in the pathogenesis of eastern equine encephalitis virus in mice Am J Pathol 166 2005 159 171 (Pubitemid 40051669)
2. S. Stienlauf, A. Eisenkraft, E. Robenshtok, and A. Hourvitz Viral encephalitis caused by biowarfare agents Harefuah 141 2002 51 56
3. A.C. Brault, A.M. Powers, C.L. Chavez, R.N. Lopez, M.F. Cachon, and L.F. Gutierrez et al. Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America Am J Trop Med Hyg 61 1999 579 586 (Pubitemid 29506338)
4. K.E. Steele, and N.A. Twenhafel REVIEW PAPER: pathology of animal models of alphavirus encephalitis Vet Pathol 47 2010 790 805
5. R.F. Feemster Outbreak of encephalitis in man due to the eastern virus of equine encephalomyelitis Am J Public Health Nations Health 28 1938 1403 1410
6. R.P. Hanson, S.E. Sulkin, E.L. Beuscher, W.M. Hammon, R.W. McKinney, and T.H. Work Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards Science 158 1967 1283 1286
7. D.S. Reed, M.G. Lackemeyer, N.L. Garza, S. Norris, S. Gamble, and L.J. Sullivan et al. Severe encephalitis in cynomolgus macaques exposed to aerosolized Eastern equine encephalitis virus J Infect Dis 196 2007 441 450 (Pubitemid 47093895)
8. J.A. Patz, S.H. Olson, C.K. Uejio, and H.K. Gibbs Disease emergence from global climate and land use change Med Clin North Am 92 2008 1473 1491
9. B.A. Wilcox, and D.J. Gubler Disease ecology and the global emergence of zoonotic pathogens Environ Health Prev Med 10 2005 263 272 (Pubitemid 41414446)
10. A. Brown, and J.E. Officer An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice Arch Virol 47 1975 123 138
11. L.F. Maire III, R.W. McKinney, and F.E. Cole Jr. An inactivated eastern equine encephalomyelitis vaccine propagated in chick-embryo cell culture. I. Production and testing Am J Trop Med Hyg 19 1970 119 122
12. J. Jose, J.E. Snyder, and R.J. Kuhn A structural and functional perspective of alphavirus replication and assembly Future Microbiol 4 2009 837 856
13. J.Y. Leung, M.M. Ng, and J.J. Chu Replication of alphaviruses: a review on the entry process of alphaviruses into cells Adv Virol 2011 2011 1 9
14. P.V. Aguilar, S.C. Weaver, and C.F. Basler Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression J Virol 81 2007 3866 3876 (Pubitemid 46586883)
15. J.H. Strauss, and E.G. Strauss The alphaviruses: gene expression, replication, and evolution Microbiol Rev 58 1994 491 562
16. J. Zhao, E.C. Sun, N.H. Liu, T. Yang, Q.Y. Xu, and Y.L. Qin et al. Phage display identifies an eastern equine encephalitis virus glycoprotein E2-specific B cell epitope Vet Immunol Immunopathol 148 2012 364 368
17. C. Pasare, and R. Medzhitov Toll-like receptors and acquired immunity Semin Immunol 16 2004 23 26 (Pubitemid 38147430)
18. F. Steinhagen, T. Kinjo, C. Bode, and D.M. Klinman TLR-based immune adjuvants Vaccine 29 2011 3341 3355
19. B.A. Beutler TLRs and innate immunity Blood 113 2009 1399 1407
20. C. Grossmann, M. Tenbusch, G. Nchinda, V. Temchura, G. Nabi, and G.W. Stone et al. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands BMC Immunol 10 2009 43
21. S. Dea, and S. Garzon Identification of coronaviruses by the use of indirect protein A-gold immunoelectron microscopy J Vet Diagn Invest 3 1991 297 305
22. H. Tayebi, A. Lienard, M. Billot, P. Tiberghien, P. Herve, and E. Robinet Detection of intracellular cytokines in citrated whole blood or marrow samples by flow cytometry J Immunol Methods 229 1999 121 130 (Pubitemid 29505188)
23. R.A. Seder, P.A. Darrah, and M. Roederer T-cell quality in memory and protection: implications for vaccine design Nat Rev Immunol 8 2008 247 258 (Pubitemid 351432801)
24. M.M. Jochim, and T.L. Barber Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis J Am Vet Med Assoc 165 1974 621 625
25. T.L. Barber, T.E. Walton, and K.J. Lewis Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses Am J Vet Res 39 1978 621 625 (Pubitemid 10205275)
26. R.J. Schoepp, J.F. Smith, and M.D. Parker Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates Virology 302 2002 299 309 (Pubitemid 35373858)
27. E. Wang, O. Petrakova, A.P. Adams, P.V. Aguilar, W. Kang, and S. Paessler et al. Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice Vaccine 25 2007 7573 7581 (Pubitemid 47503491)
28. R.P. Franklin, H. Kinde, M.T. Jay, L.D. Kramer, E.G. Green, and R.E. Chiles et al. Eastern equine encephalomyelitis virus infection in a horse from California Emerg Infect Dis 8 2002 283 288 (Pubitemid 34266266)
29. W.A. Rodriguez-Limas, K. Sekar, and K.E. Tyo Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development Curr Opin Biotechnol 24 2013 1089 1093
30. A.M. Krieg CpG motifs in bacterial DNA and their immune effects Annu Rev Immunol 20 2002 709 760 (Pubitemid 34293438)
31. A. Le Bon, C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, and U. Kalinke et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN J Immunol 176 2006 2074 2078 (Pubitemid 43201653)
32. J. Pandya, R. Gorchakov, E. Wang, G. Leal, and S.C. Weaver A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation Vaccine 30 2012 1276 1282
33. X. Wu, Q. Mao, X. Yao, P. Chen, X. Chen, and J. Shao et al. Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71 PLoS One 8 2013 e64116
34. Y. Su, L. Su, T. Yin, and B. Zhang Using reporter gene to compare infection efficiency of HIV-1 pseudovirus to suspended and adherent cells Wei Sheng Wu Xue Bao 52 2012 921 926
35. I. Skountzou, F.S. Quan, S. Gangadhara, L. Ye, A. Vzorov, and P. Selvaraj et al. Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles J Virol 81 2007 1083 1094 (Pubitemid 46167831)
36. J. Barcena, and E. Blanco Design of novel vaccines based on virus-like particles or chimeric virions Subcell Biochem 68 2013 631 665
37. R. Zhang, S. Zhang, M. Li, C. Chen, and Q. Yao Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV Vaccine 28 2010 5114 5127